Clinical Trial Update: Surgery Following Immune Checkpoint Inhibitions for Controlled Disease in Recurrent or Metastatic dMMR/MSI-H Colorectal Cancer

View source ↗

Summary

A completed clinical trial evaluated performing surgery after immune checkpoint inhibitor therapy in patients with recurrent or metastatic dMMR/MSI-H colorectal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Sun Yat-sen University | Conditions: Colorectal Cancer | Status: COMPLETED